Clearside Biomedical to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Tuesday, August 9, 2022
ALPHARETTA, Ga., July 27, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
Embedded LLM Launches the EU AI Grid at Munich Cyber Security Conference (MCSC) to Meet EU Demand for Sovereign AI Capability
Deveron Completes Transaction to Sell Its Assets